Onderneming Pandion Therapeutics, Inc.
Aandelen
PAND
US6983401067
Biotechnologie & Medisch Onderzoek
Vakgebied
Aantal werknemers: 56
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Gregg Beloff
DFI | Director of Finance/CFO | 56 | - |
Chief Tech/Sci/R&D Officer | - | 01-06-17 | |
John Sundy
CTO | Chief Tech/Sci/R&D Officer | 62 | 01-05-20 |
Edward Freedman
COO | Chief Operating Officer | 55 | - |
Michelle Avery
IRC | Investor Relations Contact | - | 01-09-20 |
Anthony Mullin
HRO | Human Resources Officer | - | - |
Kevin Otipoby
PRN | Corporate Officer/Principal | - | - |
Vikas Goyal
PRN | Corporate Officer/Principal | 45 | 01-08-19 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 29 515 583 | 21 998 484 ( 74,53 %) | 0 | 74,53 % |
Bedrijfsgegevens
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
-2,31% | 103 mld. | |
+0,56% | 95,28 mld. | |
+1,69% | 22,15 mld. | |
-17,37% | 21,02 mld. | |
-9,30% | 18,15 mld. | |
-41,01% | 16,73 mld. | |
-14,85% | 16,05 mld. | |
+3,21% | 13,68 mld. | |
+33,54% | 12,17 mld. |